Lee Willis C's Form 4 filing
Emmaus Life Sciences, Inc. (EMMA) · filed Nov 23, 2021
- Accession no.
- 0001209191-21-066428
- Filed
- Nov 23, 2021
- Trade date
- Nov 15-22, 2021
- Filing delay
- 8 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $25.6K. It was filed 8 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lee Willis CCIK 0001517775 | Director, Officer (Vice Chairman & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2021 | Common stock, $0.001 par value | PPurchaseAcquired | +1,600 | $1.24 | +$1,984 | 117,861 | Indirect | |
| Nov 16, 2021 | Common stock, $0.001 par value | PPurchaseAcquired | +2,100 | $1.29 | +$2,709 | 119,961 | Indirect | |
| Nov 17, 2021 | Common stock, $0.001 par value | PPurchaseAcquired | +1,000 | $1.29 | +$1,290 | 120,961 | Indirect | |
| Nov 19, 2021 | Common stock, $0.001 par value | PPurchaseAcquired | +5,000 | $1.37 | +$6,850 | 125,961 | Indirect | |
| Nov 22, 2021 | Common stock, $0.001 par value | PPurchaseAcquired | +8,900 | $1.44 | +$12,816 | 134,861 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.